A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)

✍ Scribed by Michele Reni; Stefano Cereda; Alessia Rognone; Carmen Belli; Michele Ghidini; Simonetta Longoni; Clara Fugazza; Sara Rezzonico; Paolo Passoni; Najla Slim; Giampaolo Balzano; Roberto Nicoletti; Stefano Cappio; Claudio Doglioni; Eugenio Villa

• Book ID: 105993727
• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 274 KB
• Volume: 69
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-011-1680-2